C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2001
11/01/2001	WO2001081391A1 A novel polypeptide, a protein 29 similar to g beta and the polynucleotide encoding the polypeptide
11/01/2001	WO2001081389A1 A novel polypeptide, human protein 9 comprising the characteristic fragment of ribosomal protein l19 and the polynucleotide encoding thereof
11/01/2001	WO2001081387A1 Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector
11/01/2001	WO2001081386A1 A novel polypeptide - human pax protein 12.5 and the polynucleotide encoding said polypeptide
11/01/2001	WO2001081385A1 A novel polypeptide, a human reductase nucleotide 9 and the polynucleotide encoding the polypeptide
11/01/2001	WO2001081384A1 A novel polypeptide-laminin 16 and the polynucleotide encoding said polypeptide
11/01/2001	WO2001081383A1 A novel polypeptide-homo phosphatase 9 and polynucleotide encoding said polypeptide
11/01/2001	WO2001081382A1 A novel polypeptide-homo hs1 protein 16 and polynucleotide encoding said polypeptide
11/01/2001	WO2001081381A1 A novel polypeptide, a human protein 11 containing site-specific recombinase characteristic sequence fragment and the polynucleotide encoding the polypeptide
11/01/2001	WO2001081380A2 Immunogenic pneumococcal protein and vaccine compositions thereof
11/01/2001	WO2001081379A2 Compounds and methods for treatment and diagnosis of chlamydial infection
11/01/2001	WO2001081378A2 G-protein coupled receptors
11/01/2001	WO2001081377A2 Integrin/adhesion antagonists
11/01/2001	WO2001081376A2 Apo-ai/aii peptide derivatives
11/01/2001	WO2001081375A2 Dna & protein binding miniature proteins
11/01/2001	WO2001081368A2 Blood-pressure reducing polypeptides containing vpp derived from microorganisms
11/01/2001	WO2001081363A1 Novel compounds
11/01/2001	WO2001081357A2 Method for indirectly extracting non-cultivable dna organisms and dna obtainable by said method
11/01/2001	WO2001081307A2 Triaryl cation antibiotics from environmental dna
11/01/2001	WO2001080965A1 Mipc column cleaning system and process
11/01/2001	WO2001080964A1 Mipc chromatographic apparatus with improved temperature control
11/01/2001	WO2001080902A2 A particulate complex for administering nucleic acid into a cell
11/01/2001	WO2001080901A2 Gene directed enzyme prodrug therapy (gdept) for cell ablation
11/01/2001	WO2001080900A2 Enhanced stabilised plasmid-lipid particle-mediated transfection using endosomal membrane
11/01/2001	WO2001080883A1 Bispecific molecules and uses thereof
11/01/2001	WO2001080881A1 Vaccine comprising a tick cement protein
11/01/2001	WO2001080875A1 A memory enhancing protein
11/01/2001	WO2001080873A2 Thrombopoietin receptor modulating peptide
11/01/2001	WO2001080840A2 Cytotoxic agents comprising single-stranded and/or looped dna
11/01/2001	WO2001080810A2 Chondroitin synthase gene and methods of making and using same
11/01/2001	WO2001080639A2 Hr-elicitors to inhibit postharvest disease or desiccation of fruits or vegetables
11/01/2001	WO2001080633A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
11/01/2001	WO2001080632A1 Cell and nonhuman animal capable of amplifying hcv
11/01/2001	WO2001080627A1 A method for plant transformation based on a pollination-fecundation pathway and the products thereof
11/01/2001	WO2001080626A1 Nucleic acids that control plant development
11/01/2001	WO2001068693A8 A novel polypeptide, human cannabinoid receptor protein 7 and the polynucleotide encoding thereof
11/01/2001	WO2001066711A8 Xylanase variants having altered sensitivity to xylanase inhibitors
11/01/2001	WO2001064883A8 Two pores potassium channel molecule and uses therefor
11/01/2001	WO2001064024B1 Multiple gene expression for engineering novel pathways and hyperexpression of foreign proteins in plants
11/01/2001	WO2001042436A3 Genes involved in cyclododecanone degradation pathway
11/01/2001	WO2001042306A3 Chimeric peptides (short b-cell epitope joined to a t-cell epitope) and their use for immunization
11/01/2001	WO2001038484A3 Moss genes from physcomitrella patens coding proteins involved in the synthesis of polyunsaturated fatty acids and lipids
11/01/2001	WO2001036641A3 DOUBLE-STRANDED RNA RECEPTOR (dsRNA-R) AND METHODS RELATING THERETO
11/01/2001	WO2001036604A3 Nucleic acids encoding endotheliases, endotheliases and uses thereof
11/01/2001	WO2001034807A3 Pectinophora gossypiella (pink bollworm) bacillus thuringiensis toxin receptor bt-r¿2?
11/01/2001	WO2001034640A3 Peptide (virip) which inhibits a circulating virus in humans and the use thereof
11/01/2001	WO2001034634A8 Tumor suppressor molecules and methods of use
11/01/2001	WO2001032866A3 Hybrid adaptor receptors
11/01/2001	WO2001029231A3 Genetic switch
11/01/2001	WO2001029204A3 Protein production system
11/01/2001	WO2001029084A3 Novel human proteins and polynucleotides encoding the same
11/01/2001	WO2001027301A3 System for rapid generation of recombinant baculovirus-based expression vectors for silkworm larvae
11/01/2001	WO2001023578A9 The gene cluster involved in aclacinomycin biosynthesis, and its use for genetic engineering
11/01/2001	WO2001021791A3 Stargazin-like neuronal ca2+-channel gamma subunit polypeptides
11/01/2001	WO2001020030A3 Nucleotide sequences derived from genes coding for trimethylamine n-oxide reductase, uses thereof in particular for detecting bacteria
11/01/2001	WO2001016374A3 Methods and reagents for in situ amplification
11/01/2001	WO2001016325A3 Plant reproduction proteins
11/01/2001	WO2001011062A3 Polyamine accumulation in plants
11/01/2001	WO2001009176A3 Mammalian cytokines; related reagents
11/01/2001	WO2001005937A3 Conversion of a watson-crick dna to a hoogsteen-paired duplex
11/01/2001	WO2000075338A3 CLONED GENONE OF INFECTIOUS HEPATITIS C VIRUS OF GENOTYPE 2a AND USES THEREOF
11/01/2001	WO2000062931A9 The use of microfluidic systems in the electrochemical detection of target analytes
11/01/2001	WO2000053757A3 Promotion or inhibition of angiogenesis and cardiovascularization
11/01/2001	WO2000047775A9 Selection of proteins using rna-protein fusions
11/01/2001	WO2000047764A3 Test kit and method for quantitatively detecting genetically modified dna in foodstuff by means of fluorescence-coupled pcr
11/01/2001	WO2000046383A8 Method of modulating metabolite biosynthesis in recombinant cells
11/01/2001	WO2000043523A3 Transgenic systems for the manufacture of poly(3-hydroxy -butyrate -co -3- hydroxyhexanoate)
11/01/2001	WO2000040607A3 Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor
11/01/2001	WO2000037662A9 S-adenosyl-l-methionine synthetase promoter and its use in expression of transgenic genes in plants
11/01/2001	WO2000034483A3 Compounds and methods for treatment and diagnosis of chlamydial infection
11/01/2001	WO2000024780A9 Compositions and methods for treating polycystic kidney disease
11/01/2001	US20010037514 Oil containing triglyceride having a 1,3-dierycoyl 2-oleoyl glycerol content of at least 50%; transgenic plants for producing seeds; lubricant additives; hydraulic oils
11/01/2001	US20010037513 Method for cloning animals with targetted genetic alterations by transfer of long-term cultured male or female somatic cell nuclei, comprising artificially-induced genetic alterations, to enucleated recipient cells
11/01/2001	US20010037183 Testing a write transducer as a reader
11/01/2001	US20010036927 Complexing
11/01/2001	US20010036925 Genetic engineering
11/01/2001	US20010036921 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
11/01/2001	US20010036919 Preventing airway mucus production by administration of EGF-R antagonists
11/01/2001	US20010036910 Detergent additive, papermaking
11/01/2001	US20010036672 Miniaturization
11/01/2001	US20010036657 Aqueous solution; ion exchanging
11/01/2001	US20010036656 Forming viruses
11/01/2001	US20010036655 Vaccine
11/01/2001	US20010036654 Transgenic plant extract
11/01/2001	US20010036651 High speed isolation of target moleculae from library
11/01/2001	US20010036649 Isolated polypeptide
11/01/2001	US20010036648 Novel compounds
11/01/2001	US20010036647 Genetic engineering
11/01/2001	US20010036638 Combinatorial enzymatic complexes
11/01/2001	US20010036635 Cancer screening
11/01/2001	US20010036632 Genetic engineering
11/01/2001	US20010036631 Detection pathological diseases or syndromes
11/01/2001	US20010036628 Inoculation, culture product, calibration
11/01/2001	US20010036462 Enhancing immunology response
11/01/2001	US20010036461 Human immunodeficiency virus vaccine
11/01/2001	US20010036460 Therapy for prostate cancer
11/01/2001	US20010036459 Cytotoxicity; therapeutic antibody
11/01/2001	US20010036456 Administering Protein C
11/01/2001	EP1144676A3 Test kit and method for quantitatively detecting genetically modified dna in foodstuff by means of fluorescence-coupled pcr
11/01/2001	EP1144642A3 Compounds and methods for treatment and diagnosis of chlamydial infection

1 ... 2951 2952 2953 2954 2955 2956 2957 2958 2959 2960 2961 2962 2963 2964 2965 2966 2967 2968 2969 2970 2971 ... 4023